Cargando…

Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States

BACKGROUND: Gaps exist in our understanding of the clinical course of pouch-related disorders. METHODS: We evaluated baseline disease activity and longitudinal treatment patterns among patients with inflammatory conditions of the pouch. RESULTS: Among 468 patients with an ileal pouch-anal anastomosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Edward L, Raffals, Laura, Long, Millie D, Syal, Gaurav, Kayal, Maia, Ananthakrishnan, Ashwin, Cohen, Benjamin, Pekow, Joel, Deepak, Parakkal, Colombel, Jean-Frederic, Herfarth, Hans H, Sandler, Robert S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380550/ https://www.ncbi.nlm.nih.gov/pubmed/32744536 http://dx.doi.org/10.1093/crocol/otaa039

Ejemplares similares

Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort
por: Barnes, Edward L, et al.
Publicado: (2023)

Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry
por: Barnes, Edward L, et al.
Publicado: (2022)

Chronic Antibiotic Dependent Pouchitis Is Associated With Older Age at the Time of Ileal Pouch Anal Anastomosis (J-pouch) Surgery
por: Weaver, Kimberly N, et al.
Publicado: (2019)

Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort
por: Bauer, Christina M, et al.
Publicado: (2020)

Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions
por: Cushing, Kelly C, et al.
Publicado: (2020)

Economic Burden of Fatigue in Inflammatory Bowel Disease
por: Ananthakrishnan, Ashwin N, et al.
Publicado: (2023)

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
por: Alayo, Quazim A, et al.
Publicado: (2022)

Home Infusions for Inflammatory Bowel Disease Are Safe: US Experience and Patient Perspectives
por: Kochar, Bharati, et al.
Publicado: (2021)

Trends and Characteristics of Clinical Trials Participation for Inflammatory Bowel Disease in the United States: A Report From IBD Partners
por: Johnson, Cole, et al.
Publicado: (2020)

Biomarkers for the Evaluation of Pouch Inflammation: A Systematic Review
por: Falloon, Katherine, et al.
Publicado: (2022)

Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients With Inflammatory Bowel Disease
por: Gregory, Martin H, et al.
Publicado: (2023)

Adjunctive Pharmacotherapy Use in Patients With Ileal Pouch-Anal Anastomosis (IPAA)
por: Nyabanga, Custon T, et al.
Publicado: (2020)

Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD
por: Click, Benjamin, et al.
Publicado: (2021)

Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications
por: Berger, Matthew, et al.
Publicado: (2020)

Management of pouch related symptoms in patients who underwent ileal pouch anal anastomosis surgery for adenomatous polyposis
por: Gilad, Ophir, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn’s Disease
por: George, Alvin T, et al.
Publicado: (2023)

Volvulus of the ileal pouch–anal anastomosis: a meta-narrative systematic review of frequency, diagnosis, and treatment outcomes
por: Jawoosh, Muhammad, et al.
Publicado: (2019)

Medical management of chronic pouch inflammation
por: Kayal, Maia, et al.
Publicado: (2022)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010–2020
por: Wewer, Mads Damsgaard, et al.
Publicado: (2022)

A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease
por: Long, Millie D, et al.
Publicado: (2021)

Reversing the Tide: Improving the Recruitment of Patients With Inflammatory Bowel Disease in Clinical Trials in the United States
por: Deepak, Parakkal
Publicado: (2020)

Pivot to Asia: inflammatory bowel disease burden
por: Singh, Prashant, et al.
Publicado: (2017)

Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection
por: Long, Millie D, et al.
Publicado: (2022)

Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease
por: Barnes, Alex, et al.
Publicado: (2023)

Patients’ Perspectives, Experiences, and Concerns With Perianal Fistulae: Insights From Online Targeted-Disease Forums
por: Khalil, Carine, et al.
Publicado: (2023)

Lower Extremity Palpable Purpura in a Patient with Quiescent Inflammatory Bowel Disease
por: Darlington, Kimberly, et al.
Publicado: (2023)

Ethnic Variation Trends in the Use of Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis
por: Hashash, Jana G, et al.
Publicado: (2023)

Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease
por: Huguet, Jose María, et al.
Publicado: (2021)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

Current Perspectives on Indications for Ileal Pouch-Anal Anastomosis in Older Patients
por: Shore, Brandon M, et al.
Publicado: (2022)

Correlation of rapid point-of-care vs send-out fecal calprotectin monitoring in pediatric inflammatory bowel disease
por: Rodriguez, Alexis, et al.
Publicado: (2017)

Disease impact on the quality of life of children with inflammatory bowel disease
por: Chouliaras, Giorgos, et al.
Publicado: (2017)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Association Between Inflammatory Bowel Disease and Pruritus
por: Iwamoto, Shiho, et al.
Publicado: (2020)

Opioid Use in Patients With Inflammatory Bowel Disease
por: Lin, Xiwu, et al.
Publicado: (2020)

Frailty in inflammatory bowel diseases: an emerging concept
por: Kochar, Bharati, et al.
Publicado: (2021)

Pyoderma Gangrenosum Is Associated With Increased Risk of Inflammatory Pouch-Related Complications: A Retrospective Cohort Study
por: Panganiban, Ronaldo Paolo, et al.
Publicado: (2023)

TELEmedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Does Not Improve Depressive Symptoms or General Quality of Life Compared With Standard Care at Tertiary Referral Centers
por: Schliep, Matthew, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oai40krpkuiriqe0g6ut43sm1l